logo Kompas.id
EnglishVaccine’s Long Road to...
Iklan

Vaccine’s Long Road to Reducing Death

Indonesia’s low vaccination coverage, even below the world average of 5 percent, has not succeeded in reducing the fatality rate (CFR) of COVID-19. The rate is still too small to provide any tangible benefits.

By
ALBERTUS KRISNA/ M PUTERI ROSALINA/SATRIO PANGARSO WISANGGENI
· 1 menit baca
https://cdn-assetd.kompas.id/oMLNB5azZkaK13J7V17b5oH7pY8=/1024x679/filters:watermark(https://cdn-content.kompas.id/umum/kompas_main_logo.png,-16p,-13p,0)/https%3A%2F%2Fkompas.id%2Fwp-content%2Fuploads%2F2021%2F06%2F20210606WEN8_1622976118.jpg
KOMPAS/P RADITYA MAHENDRA YASA

One of the residential areas of residents undergoing regional quarantine after the increase in Covid-19 cases in Pedawang Village, Bae District, Kudus Regency, Central Java, Sunday (6/6/2021).

A vaccine is not the "ultimate solution" that can prevent an explosion of COVID-10 cases. Through data analysis, the Kompas team predicts that it will take about four more years to reach optimal (vaccination) coverage to slow down the spread of the pandemic.

As of Sunday (6/6/2021), only 28.8 million doses of COVID-19 vaccines have been administered, of which 17.7 million people have received their first dose and 11.1 million their second dose — nearly six months after the vaccination rollout started in Indonesia in mid-January.

Editor:
naranasrullah
Bagikan